References
Ahmed RM, Ke YD, Vucic S, Ittner LM, Seeley W, Hodges JR et al (2018) Physiological changes in neurodegeneration-mechanistic insights and clinical utility. Nat Rev Neurol 5:5. https://doi.org/10.1038/nrneurol.2018.23
Ash PEA, Bieniek KF, Gendron TF, Caulfield T, Lin WL, DeJesus-Hernandez M et al (2013) Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron. https://doi.org/10.1016/j.neuron.2013.02.004
Davidson Y, Robinson AC, Liu X, Wu D, Troakes C, Rollinson S et al (2016) Neurodegeneration in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9orf72 is linked to TDP-43 pathology and not associated with aggregated forms of dipeptide repeat proteins. Neuropathol Appl Neurobiol. https://doi.org/10.1111/nan.12292
DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ et al (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. https://doi.org/10.1016/j.neuron.2011.09.011
Esmaeili MA, Panahi M, Yadav S, Hennings L, Kiaei M (2013) Premature death of TDP-43 (A315T) transgenic mice due to gastrointestinal complications prior to development of full neurological symptoms of amyotrophic lateral sclerosis. Int J Exp Pathol. https://doi.org/10.1111/iep.12006
Guo Y, Wang Q, Zhang K, An T, Shi P, Li Z et al (2012) HO-1 induction in motor cortex and intestinal dysfunction in TDP-43 A315T transgenic mice. Brain Res. https://doi.org/10.1016/j.brainres.2012.04.003
MacKenzie IR, Arzberger T, Kremmer E, Troost D, Lorenzl S, Mori K et al (2013) Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations. Acta Neuropathol. https://doi.org/10.1007/s00401-013-1181-y
Mackenzie IRA, Neumann M, Bigio EH, Cairns NJ, Alafuzoff I, Kril J et al (2009) Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations. Acta Neuropathol. https://doi.org/10.1007/s00401-008-0460-5
McGoldrick P, Zhang M, van Blitterswijk M, Sato C, Moreno D, Xiao S et al (2018) Unaffected mosaic C9orf72 case: RNA foci, dipeptide proteins, but upregulated C9orf72 expression. Neurology. https://doi.org/10.1212/WNL.0000000000004865
Neumann M, Bentmann E, Dormann D, Jawaid A, Dejesus-Hernandez M, Ansorge O et al (2011) FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations. Brain. https://doi.org/10.1093/brain/awr201
Proudfoot M, Gutowski NJ, Edbauer D, Hilton DA, Stephens M, Rankin J et al (2014) Early dipeptide repeat pathology in a frontotemporal dementia kindred with C9ORF72 mutation and intellectual disability. Acta Neuropathol. https://doi.org/10.1007/s00401-014-1245-7
Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J et al (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia TT—Empfindlichkeit der revidierten Diagnosekriterien der Verhaltensvariante der frontotemporalen Demenz. Brain. https://doi.org/10.1093/brain/awr179
Renton AE, Majounie E, Waite A, Simón-Sánchez J, Rollinson S, Gibbs JR et al (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. https://doi.org/10.1016/j.neuron.2011.09.010
Schludi MH, May S, Grässer FA, Rentzsch K, Kremmer E, Küpper C et al (2015) Distribution of dipeptide repeat proteins in cellular models and C9orf72 mutation cases suggests link to transcriptional silencing. Acta Neuropathol. https://doi.org/10.1007/s00401-015-1450-z
Vatsavayai SC, Yoon SJ, Gardner RC, Gendron TF, Vargas JNS, Trujillo A et al (2016) Timing and significance of pathological features in C9orf72 expansion-associated frontotemporal dementia. Brain. https://doi.org/10.1093/brain/aww250
Wilson RS, Yu L, Trojanowski JQ, Chen EY, Boyle PA, Bennett DA et al (2013) TDP-43 pathology, cognitive decline, and dementia in old age. JAMA Neurol. https://doi.org/10.1001/jamaneurol.2013.3961
Acknowledgements
The authors wish to thank the patient and her family for their invaluable contributions to neurodegeneration research. The authors also wish to thank Dr. Leonard Petrucelli and his group at the Mayo Clinic Florida for contributing dipeptide repeat protein antibodies. This work was supported by NIH grants AG023501 and AG019724, the Tau Consortium, and the Bluefield Project to Cure FTD.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest relevant to this article to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Sampognaro, P.J., Vatsavayai, S.C., Cosme, C.G. et al. C9orf72-specific phenomena associated with frontotemporal dementia and gastrointestinal symptoms in the absence of TDP-43 aggregation. Acta Neuropathol 138, 1093–1097 (2019). https://doi.org/10.1007/s00401-019-02084-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-019-02084-y